These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18161111)

  • 1. [Biochemical markers of bone turnover: Serum P1NP].
    Imanishi Y; Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():231-5. PubMed ID: 18161111
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical markers for bone turnover: Serum beta-CTX].
    Ichimura S; Iwamoto J
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():237-44. PubMed ID: 18161112
    [No Abstract]   [Full Text] [Related]  

  • 3. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
    Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract]   [Full Text] [Related]  

  • 5. [N-terminal propeptide of type I procollagen (PINP)].
    Sone T; Fukunaga M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():232-5. PubMed ID: 15658307
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Turek S; Kusec V; Duraković Z
    Coll Antropol; 1999 Jun; 23(1):195-201. PubMed ID: 10402723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism.
    Sodi R; Hazell MJ; Durham BH; Rees C; Ranganath LR; Fraser WD
    Clin Biochem; 2009 Sep; 42(13-14):1375-80. PubMed ID: 19523465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
    Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
    Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
    Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
    Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carboxyl-terminal propeptide of type I collagen(PICP)].
    Inaba M; Ueda M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():345-8. PubMed ID: 15035149
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?
    Devogelaer JP; Boutsen Y; Gruson D; Manicourt D
    Rheum Dis Clin North Am; 2011 Aug; 37(3):365-86, v-vi. PubMed ID: 22023897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of biochemical markers of bone turnover in diagnosis of osteoporosis].
    Pluskiewicz W; Stempniewicz E
    Przegl Lek; 1994; 51(3):149-51. PubMed ID: 8058983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.